Researchers develop promising recombinant flu vaccine using nanoliposome technology

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 71%

United Kingdom Headlines News

United Kingdom Latest News,United Kingdom Headlines

Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines.

Feb 24 2024University at Buffalo

A University at Bufalo-led research team hopes to add to that number. It is developing a new recombinant flu vaccine – described in a study published today in the journal Cell Reports Medicine – that has the potential to compete with existing vaccines. Conventional flu vaccines contain either deactivated microbes that cause influenza, or they are based on weakened forms of the disease. They are made using fertilized chicken eggs or, less commonly, through cell culture-based production.

In the new study, the team attached to the nanoliposome a total of six proteins – three each from two different protein groups, hemagglutinins and neuraminidases. The team also added two adjuvants to boost immune response. The tests were performed via vaccination and through blood serum transfer from vaccinated mice into non-vaccinated mice.

Source: Tech Daily Report (techdailyreport.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Researchers identify potential way to treat genetic epilepsy by replacing 'lost' enzymeScientists at the Francis Crick Institute have found a new treatment target for CDKL5 deficiency disorder (CDD), one of the most common types of genetic epilepsy.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers uncover how deadly MRSA pneumonia inhibits body's antimicrobial activityResearchers examined how heparan sulfate (HS) shedding impacts cathelicidin efficacy in Methicillin-Resistant Staphylococcus aureus (MRSA) pneumonia.
Source: NewsMedical - 🏆 19. / 71 Read more »

Researchers receive £2.4 million to generate evidence on the new NHS Pharmacy First serviceResearchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2.4m by the National Institute for Health and Care Research (NIHR) to generate evidence on the new National Health Service (NHS) Pharmacy First service.
Source: NewsMedical - 🏆 19. / 71 Read more »

Researchers develop model to assess biology of human placental barrierDuring pregnancy, the human placenta plays multiple essential roles, including hormone production and nutrient/waste processing. It also serves as a barrier to protect the developing fetus from external toxic substances. However, the placental barrier can still be breached by certain drugs.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers create machine learning-based classifier that could aid early diagnosis of psychosisThe onset of psychosis can be predicted before it occurs, using a machine-learning tool which can classify MRI brain scans into those who are healthy and those at risk of a psychotic episode.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers uncover key molecule influencing vascular agingA new study shows how the molecule Sox9 is involved in a positive feedback loop that accelerates the aging of blood vessels, which could be used as a target for new therapies.
Source: medical_xpress - 🏆 101. / 51 Read more »